| Miss Christina Graham, APRN | |
|
2209 Arbor Cir Apt 35, Downers Grove, IL 60515-2521 | |
| (630) 229-1353 | |
| Not Available |
| Full Name | Miss Christina Graham |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 2209 Arbor Cir Apt 35, Downers Grove, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154730323 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | 277.001020 (Illinois) | Primary |
| Entity Name | Rush Oak Park Physicians Group Adult Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548531924 PECOS PAC ID: 3476716523 Enrollment ID: O20120529000606 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21").
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
The one-year anniversary of the Family Smoking Prevention and Tobacco Control Act brings new consumer protections that will make it increasingly difficult for the tobacco industry to recruit the next Marlboro man, woman or child. With many important provisions already in effect, we can celebrate the lives we have saved with rules restricting Big Tobacco's deceptive marketing practices, particularly towards children.
› Verified 8 days ago
| Entity Name | Rush Oak Park Physicians Group North Riverside |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003186255 PECOS PAC ID: 9931363710 Enrollment ID: O20120606000616 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21").
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
The one-year anniversary of the Family Smoking Prevention and Tobacco Control Act brings new consumer protections that will make it increasingly difficult for the tobacco industry to recruit the next Marlboro man, woman or child. With many important provisions already in effect, we can celebrate the lives we have saved with rules restricting Big Tobacco's deceptive marketing practices, particularly towards children.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Christina Graham, APRN 2209 Arbor Cir Apt 35, Downers Grove, IL 60515-2521 Ph: (630) 229-1353 | Miss Christina Graham, APRN 2209 Arbor Cir Apt 35, Downers Grove, IL 60515-2521 Ph: (630) 229-1353 |
News Archive
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21").
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
The one-year anniversary of the Family Smoking Prevention and Tobacco Control Act brings new consumer protections that will make it increasingly difficult for the tobacco industry to recruit the next Marlboro man, woman or child. With many important provisions already in effect, we can celebrate the lives we have saved with rules restricting Big Tobacco's deceptive marketing practices, particularly towards children.
› Verified 8 days ago
Theresa Dolan, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1038 Fax: 630-829-1080 | |
Mrs. Tamyra Michelle Janicki, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1315 Butterfield Rd Ste 206, Downers Grove, IL 60515 Phone: 630-317-7690 Fax: 630-317-7894 | |
Mrs. Ebonique Thomson, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3005 Highland Pkwy, Downers Grove, IL 60515 Phone: 716-249-1820 | |
Mansi P Patel, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1441 Branding Ave, Ste 310, Downers Grove, IL 60515 Phone: 312-609-0300 | |
Ms. Elizabeth Sowa, MSN, ANP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1084 | |
Letasha Lewis, MSN, FNP-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 900 Ogden Ave # 335, Downers Grove, IL 60515 Phone: 773-234-0388 Fax: 773-234-0394 | |
Lizeht Monarrez, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1441 Branding Ave Ste 310, Downers Grove, IL 60515 Phone: 630-829-1084 |